Calidi Biotherapeutics (CLDI) Q2 2024 Earnings

14MayConfirmed
Q2 2024
-2.75
-2.5
-2.25
-2

Details

Expected EPS
-2.75
Actual EPS
-2
Surprise EPS
0.75
Surprise Percent
+27.27%

Description

Calidi Biotherapeutics (CLDI) has reported earnings of -2 per share for Q2 2024.

0 Comments

Share your thoughts